Puma Biotechnology Inc revenue breakdown overview

Puma Biotechnology Inc revenue for the last year amounted to 230.50 M USD, the most of which — 230.47 M USD — came from its highest performing source at the moment, Cancer Care Products, the year earlier bringing 235.64 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Puma Biotechnology Inc 230.47 M USD, and the year before that — 235.64 M USD.